Abstract Library

#2899 Using Long-Acting Somatostatin Analogue as Adjuvant Therapy for Post Resection Grade 2 Pancreatic Neuroendocrine Tumor: Interim Results from an Ongoing Multicenter Real-World Study in China

Introduction: Surgery was the preferred treatment in patients with resectable pancreatic neuroendocrine tumor (pNET), but recurrent lesion relapsed frequently within a short time. It was controversial whether patients with pNET need adjuvant therapy after surgery.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Shi X

Authors: Shi X, Xu X, Zhang Y, Gao S, Li B,

Keywords: somatostatin analogue, adjuvant therapy, pancreatic neuroendocrine tumor,

#2714 The Clinical Outcome of Non-Curative Resection of Small Rectal Neuroendocrine Tumours

Introduction: Small rectal NETs are thought to be less aggressive and relatively benign. However, lymphovascular invasion(LVI) or positive margin after endoscopic resection(ER) was noticed in small rectal NETs.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Hu H, Li R, Xu R, Zhang S,

Keywords: rectal neuroendocrine tumors, lymphovascular invasion, non-curative, endoscopic resection,

#1260 Immunohistochemical Expressions in Hepatic Nonfunctional Neuroendocrine Neoplasms with Unknown Origins

Introduction: Liver metastasis is common in neuroendocrine neoplasms, but many patients could not reveal their origins during their career.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Xin B, Lou W, Ji Y, Xie Y, Xu X,

Keywords: ihc, tma, lm, nen,

#1259 Expressions of ATRX and DAXX in Hepatic Metastatic Pancreatic Nonfunctional Neuroendocrine Neoplasms

Introduction: Loss of ATRX or DAXX is common in well-differentiated pancreatic neuroendocrine neoplasms, and is correlated with higher tumor stage and shorter survival time.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Xin B, Lou W, Ji Y, Xie Y, Xu X,

Keywords: atrx, daxx, hepatic lesion, pnen, tma,

#1258 Expressions of CK 19 and CD117 in Hepatic Metastatic Pancreatic Nonfunctional Neuroendocrine Neoplasms

Introduction: The expressions of CK19 and CD117 in pancreatic neoruendocrine neoplasms were considered dismal prognostic factors in some studies, but inconsistent in others.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Xin B, Lou W, Ji Y, Xie Y, Xu X,

Keywords: CK19, CD117, pNEN, LM, TMA,